The role of molecular genetics in diagnosing familial hematuria(s)

Pediatric Nephrology

Volumn 27, Issue 8, 2012, Pages 1221-1231

  Deltas, Constantinos ^a   Pierides, Alkis ^b   Voskarides, Konstantinos ^a  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b Hippocrateon Hospital   (Cyprus)

Author keywords

Alport syndrome; C3 glomerulonephritis; CFHR5 nephropathy; Collagen IV; Complement; Familial hematuria; Microscopic hematuria; Thin Basement Membrane Nephropathy

Indexed keywords

COLLAGEN TYPE 4; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

AGE; ALPORT SYNDROME; CHRONIC KIDNEY DISEASE; DISEASE COURSE; GENE MUTATION; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THIN BASEMENT MEMBRANE NEPHROPATHY;

HEMATURIA; HUMANS; KIDNEY DISEASES; MOLECULAR BIOLOGY;

EID: 84863984599     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1935-5     Document Type: Review

References (72)

1. Fogazzi GB, Edefonti A, Garigali G, Giani M, Zolin A, Raimondi S, Mihatsch MJ, Messa P (2008) Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy. Pediatr Nephrol 23:1093-1100
2. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA (2001) Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 69:1033-1045 (Pubitemid 33015818)
3. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A (2003) MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82:203-215 (Pubitemid 36578709)
4. Kashtan CE (2009) Familial hematuria. Pediatr Nephrol 24:1951-1958
5. Alport AC (1927) Hereditary familial congenital haemorrgagic nephritis. BMJ 1:504-506
6. Kashtan CE (2005) Familial hematurias: what we know and what we don't. Pediatr Nephrol 20:1027-1035 (Pubitemid 41001540)
7. Slajpah M, Gorinsek B, Berginc G, Vizjak A, Ferluga D, Hvala A, Meglic A, Jaksa I, Furlan P, Gregoric A, Kaplan-Pavlovcic S, Ravnik-Glavac M, Glavac D (2007) Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria. Kidney Int 71:1287-1295 (Pubitemid 46884250)
8. Haas M (2009) Alport syndrome and thin glomerular basement nephropathy: a practical approach to diagnosis. Arch Pathol Lab Med 133:224-232
9. Hanson H, Storey H, Pagan J, Flinter F (2011) The value of clinical criteria in identifying patients with X-linked Alport syndrome. Clin J Am Soc Nephrol 6:198-203
10. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 14:2603-2610 (Pubitemid 37169346)
11. Kashtan CE (2007) Alport syndrome and the X chromosome: implications of a diagnosis of Alport syndrome in females. Nephrol Dial Transplant 22:1499-1505 (Pubitemid 47073745)
12. Longo I, Scala E, Mari F, Caselli R, Pescucci C, Mencarelli MA, Speciale C, Giani M, Bresin E, Caringella DA, Borochowitz ZU, Siriwardena K, Winship I, Renieri A, Meloni I (2006) Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families. Nephrol Dial Transplant 21:665-671 (Pubitemid 43372912)
13. Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frasca G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M (2002) COL4A3/COL4A4 mutations: from benign familial hematuria to autosomal dominant or recessive Alport syndrome. Kidney Int 61:1947-1956 (Pubitemid 34539312)
14. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (2003) Thin basement membrane nephropathy. Kidney Int 64:1169-1178 (Pubitemid 37153781)
15. Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Kyriacou K, Deltas C (2009) Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant 24:2721-2729
16. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, Adam G, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides C, Deltas C, Palmer A, Frémeaux-Bacchi V, Cordoba SR, Maxwell PH, Pickering MC (2010) Complement factor H-related protein 5 (CFHR5) nephropathy: an endemic cause of renal disease in Cyprus. Lancet 376:794-801
17. Athanasiou Y, Voskarides K, Gale D, Damianou L, Patsias C, Zavros M, Maxwell P, Cook T, Demosthenous P, Hatjisavvas A, Kyriacou K, Zouvani I, Pierides M, Deltas C (2011) Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol. Clin J Am Soc Nephrol 6:1436-1446
18. Paterson AD, Liu XQ, Wang K, Magistroni R, Song X, Kappel J, Klassen J, Cattran D, St George-Hyslop P, Pei Y (2007) Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol 18:2408-2415 (Pubitemid 47203857)
19. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP (2011) Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43:321-327
20. Coppo R, Gianoglio B, Porcellini MG, Maringhini S (1998) Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant 13:293-297 (Pubitemid 28062187)
21. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schröder CH, Smeets HJ, Reeders ST (1994) Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77-81 (Pubitemid 2122272)
22. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556 (Pubitemid 36706542)
23. LeBleu VS, Macdonald B, Kalluri R (2007) Structure and function of basement membranes. Exp Biol Med (Maywood) 232:1121-1129 (Pubitemid 47503053)
24. Khoshnoodi J, Pedchenko V, Hudson BG (2008) Mammalian collagen IV. Microsc Res Tech 71:357-1370
25. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-Linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649-657 (Pubitemid 30171874)
26. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M (2002) Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counseling. Nephrol Dial Transplant 17:1218-1227 (Pubitemid 34812066)
27. Habib R, Gubler MC, Hinglais N, Noel LH, Droz D, Levy M, Mahieu P, Foidart JM, Perrin D, Bois E, Grunfeld JP (1982) Alport syndrome: experience at Hôpital Necker. Kidney Int 11: S20-S28
28. Cangiotti AM, Sessa A, Meroni M, Montironi R, Ragaiolo M, Mambelli M, Cinti S (1996) Evolution of glomerular basement membrane lesions in a male patient with Alport syndrome: ultrastructural and morphometric study. Nephrol Dial Transplant 11:1829-1834 (Pubitemid 26297572)
29. Moghal NE, Milford DV, White RHR, Raafat F, Higgins R (1999) Coexistence of thin membrane and Alport nephropathies in families with hematuria. Pediatr Nephrol 13:778-781
30. Thorner PS (2007) Alport syndrome and thin basement membrane nephropathy. Nephron Clin Pract 106:82-88
31. Wei G, Zhihong L, Huiping C, Caihong Z, Zhaohong C, Leishi L (2006) Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome. Nephrol Dial Transplant 21:3146-3154 (Pubitemid 44567087)
32. Bekheirnia MR, Reed B, Gregory MC, McFann K, Shamshirsaz AA, Masoumi A, Schrier RW (2010) Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol 21:876-883
33. Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz JM, Barker D, Gregory M, Atkin C, Styrkarsdottir U, Neumann H, Springate J, Shows T, Pettersson E, Tryggvason K (1998) High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 9:2291-2301 (Pubitemid 28543807)
34. Barker DF, Denison JC, Atkin CL, Gregory MC (2001) Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP. Am J Med Genet 98:148-160 (Pubitemid 32051803)
35. Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, Ioannou K, Athanasiou Y, Patsias C, Alexopoulos E, Pierides A, Kyriacou K, Deltas C (2007) COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol 18:3004-3016 (Pubitemid 350058408)
36. Demosthenous P, Voskarides K, Stylianou K, Hadjigavriel M, Arsali M, Patsias C, Georgaki E, Zirogiannis P, Stavrou C, Daphnis E, Pierides A, Deltas C, the Hellenic Nephrogenetics Research Consortium (2011) X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5. Clin Genet. doi:10.1111/j.1399- 0004.2011.01647.x
37. Kaneko K, Tanaka S, Hasui M, Nozu K, Krol RP, Iijima K, Sugimoto K, Takemura T (2010) A family with X-linked benign familial hematuria. Pediatr Nephrol 25:545-548
38. Becknell B, Zender GA, Houston R, Baker PB, McBride KL, Luo W, Hains DS, Borza DB, Schwaderer AL (2011) Novel X-linked glomerulopathy is associated with a COL4A5 missense mutation in a non-collagenous interruption. Kidney Int 79:120-127
39. Lemmink HH, Nillesen WN, Mochizuki T, Schroder CH, Brunner HG, van Oost BA, Monnens LA, Smeets HJ (1996) Benign familial. hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98:1114-1118 (Pubitemid 26299923)
40. Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J (2001) COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome. Kidney Int 60:480-483 (Pubitemid 32678891)
41. Ozen S, Ertoy D, Heidet L, Cohen-Solal L, Ozen H, Besbas N, Bakkaoglu A, Antignac C (2001) Benign familial hematuria associated with a novel COL4A4 mutation. Pediatr Nephrol 16:874-877 (Pubitemid 33040644)
42. Badenas C, Praga M, Tazon B, Heidet L, Arrondel C, Armengol A, Andrés A, Morales E, Camacho JA, Lens X, Dávila S, Milà M, Antignac C, Darnell A, Torra R (2002) Mutations in the COL4A4 and COL4A3 genes cause familial benign hematuria. J Am Soc Nephrol 13:1248-1254 (Pubitemid 34441405)
43. Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J (2003) Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int 63:447-453 (Pubitemid 36126791)
44. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M (2003) Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome. Nephrol Dial Transplant 18:1122-1127 (Pubitemid 36722513)
45. Tazon Vega B, Badenas C, Ars E, Lens X, Mila M, Darnell A, Torra R (2003) Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases. Am J Kidney Dis 42:952-959 (Pubitemid 37322912)
46. Wang YY, Rana K, Tonna S, Llin T, Sin L, Savige J (2004) COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN). Kidney Int 65:786-790 (Pubitemid 38251054)
47. Rana K, Tonna S, Wang YY, Sin L, Lin T, Shaw E, Mookerjee I, Savige J (2007) Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. Pediatr Nephrol 22:652-657 (Pubitemid 46691519)
48. Baek JI, Choi SJ, Park SH, Choi JY, Kim CD, Kim YL, Kim UK (2009) Identification of novel variants in the COL4A4 gene in Korean patients with thin basement membrane nephropathy. Indian J Med Res 129:525-533
49. Endreffy E, Ondrik Z, Iványi B, Maróti Z, Bereczki C, Haszon I, Györke Z, Worum E, Németh K, Rikker C, Ökrös Z, Túri S (2011) Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families. Mol Cell Probes 25:28-34
50. Nieuwhof CMG, de Heer F, de Leeuw P, van Breda Vriesman PJC (1997) Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 51:1596-1601 (Pubitemid 27239917)
51. Nogueira M, Cartwright J Jr, Horn K, Doe N, Shappell S, Barrios R, Coroneos E, Truong LD (2000) Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. Am J Kidney Dis 35:E15
52. van Paasen P, van Breda Vriesman PJC, van Rie H, Tervaert JWC (2004) Signs and symptoms of thin basement membrane nephrop-athy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. Kidney Int 66:909-913 (Pubitemid 39120991)
53. Norby SM, Cosio FG (2005) Thin basement membrane nephrop-athy associated with other glomerular diseases. Semin Nephrol 25:176-179 (Pubitemid 40692801)
54. Haas M (2006) Thin glomerular basement membrane nephropa-thy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch Pathol Lab Med 130:699-706 (Pubitemid 43736874)
55. Gregory MC (2005) The clinical features of thin basement membrane nephropathy. Semin Nephrol 25:140-145 (Pubitemid 40692795)
56. Deltas C (2009) Thin basement membrane nephropathy: is there genetic predisposition to more severe disease? Pediatr Nephrol 24:877-879
57. Hoefele J, Lange-Sperandio B, Ruessmann D, Glöckner-Pagel J, Alberer M, Benz MR, Nagel M, Weber LT (2010) Novel heterozygous COL4A3 mutation in a family with late-onset ESKD. Pediatr Nephrol 25:1539-1542
58. McRae JL, Cowan PJ, Power DA, Mitchelhill KI, Kemp BE, Morgan BP, Murphy BF (2001) Human factor H-related protein 5 (FHR-5) A new complement-associated protein. J Biol Chem 276:6747-6754
59. Murphy B, Georgiou T, Machet D, Hill P, McRae J (2002) Factor H-related protein-5: a novel component of human glomerular immune deposits. Am J Kidney Dis 39:24-27 (Pubitemid 34062491)
60. Sirbat D, Saudax E, Hurault de Ligny B, Bene MC, Raspiller A (1983) A new etiology of episcleritis: nephropathies with IgA and/or isolated C3 deposits. J Fr Ophthalmol 6:921-925 (Pubitemid 14158986)
61. Grekas D, Morley AR, Wilkinson R, Kerr DNS (1984) Isolated C3 deposition in patients without systemic disease. Clin Nephrol 21:270-274 (Pubitemid 14102532)
62. Manno C, Proscia AR, Laraia E, Gianarande M, Di Cario M, Salvatore C, Tasc A, Schena FP, Rita S (1990) Clinicopathological features in patients with isolated C3 mesangial proliferative glomerulonephritis. Nephrol Dial Transplant 5(s):78-80 (Pubitemid 20289999)
63. Gallego N, Teruel JL, Mampaso F, Gonzalo A, Ortuno J (1991) Acute interstitial nephritis superimposed on glomerulonephritis: report of a case. Pediatr Nephrol 5:229-231
64. Calls Ginesta J, Almirall J, Torras A, Darnell A, Revert L (1995) Long-term evolution of patients with isolated C3 mesangial glomerulonephritis. Clin Nephrol 43:221-225
65. Yagi K, Yanagida H, Sugimoto K, Kuwajima H, Tabata N, Morita K, Okada M, Takemura T (2005) Clinicopathologic features, outcome and therapeutic interventions in four children with glomerulonephritis. Pediatr Nephrol 20:1273-1278 (Pubitemid 41222974)
66. Abrera-Abeleda MA, Nishimura C, Smith JLH, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Jozsi M, Zipfel PF, Hageman GS, Smith RJH (2006) Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet 43:582-589 (Pubitemid 44048765)
67. Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grunfeld J-P, Lesavre P, Noel L-H, Fakhouri F (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193-199 (Pubitemid 46580528)
68. Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka Ch, Kirschfink M, Hoppe B, Zipfel PF, Licht Ch (2009) C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75:1230-1234
69. Kim BS, Kim YK, Shin YS, Kim YO, Song HC, Kim YS, Choi EJ (2009) Natural history and renal pathology in patients with isolated microscopic hematuria. Korean J Intern Med 24:356-361
70. Fuiano G, Mazza G, Comi N, Caglioti A, De Nicola L, Iodice C, Andreucci M, Andreucci VE (2000) Current indications for renal biopsy: a questionnaire-based survey. Am J Kidney Dis 35:448-457
71. Parone DB, Meyer LE (1981) The effect of biopsy on therapy in renal disease. Arch Intern Med 141:1039-1041 (Pubitemid 11067841)
72. Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31:E1445-E1460